Cellebrite DI Ltd. CLBT
12.45 USD +0.07 (+0.57%)
At closeNov 6, 2026, 4:00 PM EST
12.45 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
12.18 Day range 12.51
9.58 52-week range 19.98
- YTD
- -30.95%
- 1 year
- -18.41%
Financial health
Altman Z-Score
5.08 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
B+3 / 5 overall
- DCF 4
- Return on Equity 3
- Return on Assets 4
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E 58.2×
FY 2019 5y median 6.8× FY 2025
P/S 9.5×
FY 2019 5y median 5.1× FY 2025
P/B 9.3×
FY 2019 5y median 10.8× FY 2025
P/FCF 28.9×
FY 2019 5y median 38.0× FY 2025
EV/EBITDA 42.7×
FY 2019 5y median 5.6× FY 2025
EV/Sales 9.3×
FY 2019 5y median 4.5× FY 2025
FCF Yield 3.5%
FY 2019 5y median 2.6% FY 2025
Profitability
Gross Margin 84.2%
FY 2019 5y median 83.6% FY 2025
Operating Margin 14.0%
FY 2019 5y median 10.2% FY 2025
Net Margin 16.5%
FY 2019 5y median 16.5% FY 2025
ROE 16.2%
FY 2019 5y median -84.2% FY 2025
ROIC 10.0%
FY 2019 5y median 10.0% FY 2025
ROA 8.3%
FY 2019 5y median 8.3% FY 2025
Growth (YoY)
Revenue 18.6%
FY 2019 FY 2025
Operating Income 16.8%
FY 2019 FY 2025
EPS (diluted) 123.0%
FY 2019 FY 2025
Free Cash Flow 28.1%
FY 2019 FY 2025
Financial Health
Current Ratio 1.6×
FY 2019 5y median 1.6× FY 2025
Quick Ratio 1.5×
FY 2019 5y median 1.5× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA -1.0×
FY 2019 5y median -0.6× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.2× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31